Quest PharmaTech Inc. (CVE:QPT – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Friday . The company traded as low as C$0.02 and last traded at C$0.02, with a volume of 14000 shares traded. The stock had previously closed at C$0.03.
Quest PharmaTech Price Performance
The company has a quick ratio of 0.52, a current ratio of 0.26 and a debt-to-equity ratio of 1.51. The business’s 50-day simple moving average is C$0.03 and its 200-day simple moving average is C$0.04. The stock has a market cap of C$3.38 million, a PE ratio of -0.17 and a beta of 0.29.
About Quest PharmaTech
Quest PharmaTech Inc, a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer.
Read More
- Five stocks we like better than Quest PharmaTech
- What are earnings reports?
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- How to Capture the Benefits of Dividend Increases
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- What Investors Need to Know to Beat the Market
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Quest PharmaTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quest PharmaTech and related companies with MarketBeat.com's FREE daily email newsletter.
